Neuroprotection in the rat Parkinson model by intrastriatal GDNF gene transfer using a lentiviral vector

Neuroreport
Biljana GeorgievskaAnders Björklund

Abstract

We used a recombinant lentiviral vector (rLV) for gene delivery of GDNF to the striatum, and assessed its neuroprotective effects in the intrastriatal 6-hydroxydopamine (6-OHDA) lesion model. The level of GDNF expression obtained with the rLV-GDNF vector was dose-related and ranged between 0.9-9.3 ng/mg tissue in the transduced striatum, as determined by ELISA, and 0.2-3.0 ng/mg tissue were detected in the ipsilateral substantia nigra (SN), due to anterograde transport of the GDNF protein. GDNF expression was apparent at 4 days and maintained for > 8 months after injection. Striatal delivery of rLV-GDNF efficiently protected the nigral dopamine (DA) neurons and their projection, against the 6-OHDA lesion (65-77% of intact side). Sprouting of the lesioned axons was observed along the nigrostriatal pathway, precisely corresponding to the areas containing anterogradely transported GDNF.

References

Nov 5, 1997·Nature Biotechnology·R ZuffereyD Trono
Oct 10, 1998·Journal of Virology·T DullL Naldini
Dec 28, 1999·Brain : a Journal of Neurology·P F ChinneryT D Griffiths
Jan 12, 2000·Experimental Neurology·J H KordowerP Aebischer

❮ Previous
Next ❯

Citations

Aug 24, 2004·Cell and Tissue Research·O Eberhardt, J B Schulz
Jul 17, 2008·Molecular Therapy : the Journal of the American Society of Gene Therapy·Melissa K McCoyMalú G Tansey
Jul 25, 2013·Molecular Therapy : the Journal of the American Society of Gene Therapy·Luis QuintinoCecilia Lundberg
Aug 6, 2013·Molecular Therapy : the Journal of the American Society of Gene Therapy·D Eugene RedmondJohn R Sladek
Dec 14, 2006·Molecular Therapy : the Journal of the American Society of Gene Therapy·Mehdi GasmiRaymond T Bartus
Feb 8, 2003·DNA and Cell Biology·Ricardo Quinonez, Richard E Sutton
Jun 30, 2011·Brain : a Journal of Neurology·Mickael DecressacAnders Björklund
Apr 13, 2004·Neuroreport·Mimoun AzzouzNicholas D Mazarakis
Jan 13, 2006·Neuroreport·Marcel M DaadiKrys S Bankiewicz
Aug 20, 2003·Neurosurgery·E Antonio Chiocca
Mar 8, 2006·Reviews in the Neurosciences·Dorit Ron, Patricia H Janak
Nov 13, 2008·CNS Drugs·Fabio FumagalliMarco Andrea Riva
Jul 20, 2007·Regenerative Medicine·Joanna A KoreckaElly M Hol
Oct 7, 2004·Proceedings of the National Academy of Sciences of the United States of America·Antonella ConsiglioLuigi Naldini
Jul 18, 2014·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Yi ZhangHaihong Wang
Dec 31, 2003·Experimental Neurology·Carrie B Hurelbrink, Roger A Barker
Mar 14, 2007·Current Opinion in Neurology·Monica Cardone
Jul 2, 2008·Expert Review of Neurotherapeutics·Murray HongIvar Mendez
Nov 22, 2005·Expert Opinion on Drug Delivery·Tom H JohnstonJonathan M Brotchie
Mar 1, 2011·Progress in Neuro-psychopharmacology & Biological Psychiatry·Yeni KimSoon Young Shin
Apr 28, 2009·Advanced Drug Delivery Reviews·Knut StiegerFabienne Rolling
Jan 13, 2009·Pharmacology & Therapeutics·Sebastien Carnicella, Dorit Ron
Oct 13, 2004·Phytotherapy Research : PTR·Bala V ManyamTheodore A Hare
Jan 6, 2004·Journal of Neurobiology·Christopher S von Bartheld
Jul 13, 2004·Annals of the New York Academy of Sciences·Soshana Behrstock, Clive N Svendsen
Jan 8, 2009·Annals of Neurology·Ole Isacson, Jeffrey H Kordower
Jan 25, 2011·The Mount Sinai Journal of Medicine, New York·Dustin R WakemanJeffrey H Kordower
Feb 8, 2013·Movement Disorders : Official Journal of the Movement Disorder Society·Jeffrey H Kordower, Anders Bjorklund

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.

Astrocytes in Parkinson Disease

Parkinson's disease (PD) is a neurodegenerative disorder caused by the progressive loss of dopaminergic neurons. Some PD-genes may be associated with astrocyte dysfunction. Discover the latest research on astrocytes in Parkinson's disease here.